Sage Journals: Discover world-class research

Retricted access

Review article

First published 2020-9

A review of Osimertinib in NSCLC and pharmacist role in NSCLC patient care

Osama M Al-Quteimat, Amer M Amer

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2020

Downregulation of circRNA_100876 Inhibited Progression of NSCLC In Vitro via Targeting miR-636

Jianxiang Song, Woda Shi, Zhengya Gao [...]

Technology in Cancer Research & Treatment

Free access

Review article

First published 2016-5

Nintedanib in NSCLC: evidence to date and place in therapy

Giuseppe Bronte, Francesco Passiglia, Antonio Galvano [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2018-10

Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cells

Ying Ma, Shirong Kang, Xu Wu [...]

Tumori Journal

Free access

Research article

First published 2020-11

Circ_0000376 enhances the proliferation,metastasis,and chemoresistance of NSCLC cells via repressing miR-384

Hui Sun, Yi Chen, Yue-Yu Fang [...]

Cancer Biomarkers

Free access

Research article

First published 2022-2

The clinical significance and function of EGFR mutation in TKI treatments of NSCLC patients

Hao Ding, Yuxing Chen, Yuanyang Zhao [...]

Cancer Biomarkers

Free access

Case report

First published 2018-11

Coexistence of three EGFR mutations in an NSCLC patient: A brief report

Francesca Belardinilli, Angela Gradilone, Alain Gelibter [...]

The International Journal of Biological Markers

Free access

Research article

First published 2022-8

Prognostic significance of a complement factor H autoantibody in early stage NSCLC

Elizabeth B. Gottlin, Michael J. Campa, Rikesh Gandhi [...]

Cancer Biomarkers

Open access

Review article

First published 2025-05

Advances and Future Perspectives of HER2 Mutations in Non-Small Lung Cancer (NSCLC),Especially in China

Chang Liu, Tao Li, Xiaoran Cui [...]

Cancer Control

Retricted access

Case report

First published 2020-12

Recurrent thrombosis followed by Lazarus response in ROS1 rearranged NSCLC treated with crizotinib: a case report

Teresa Beninato, Giuseppe Lo Russo, Marina Chiara Garassino [...]

Tumori Journal

Search results